{{cart_num}}
My CartCAS：69884-00-0
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 69884-00-0 |
| Name | Pseudoginsenoside F11 |
| Molecular Formula | C42H72O14 |
| Molecular Weight | 801.01 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD00803938 |
| SMILES | C[C@@]([C@@]12C)(C[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]3O)([H])[C@@H]3O[C@@](O[C@@H](C)[C@H](O)[C@H]4O)([H])[C@@H]4O)[C@@]5([H])C6(C)C)[C@@](C[C@@H](O)[C@]1([H])[C@]([C@]7(O[C@@H](C(C)(O)C)CC7)C)([H])CC2)([H])[C@]5(CC[C@@H]6O)C |
| InChIKey | JBGYSAVRIDZNKA-NKECSCAMSA-N |
| InChI | InChI=1S/C42H72O14/c1-19-28(46)30(48)32(50)35(52-19)55-33-31(49)29(47)23(18-43)54-36(33)53-22-17-41(8)24(39(6)13-11-25(45)37(2,3)34(22)39)16-21(44)27-20(10-14-40(27,41)7)42(9)15-12-26(56-42)38(4,5)51/h19-36,43-51H,10-18H2,1-9H3/t19-,20-,21+,22-,23+,24+,25-,26+,27-,28-,29+,30+,31-,32+,33+,34-,35-,36+,39+,40+,41+,42-/m0/s1 |
| PubChem CID | 21633072 |
| Target Point | PPARγ |
| Passage | Cell Cycle;DNA Damage/DNA Repair;Metabolic Enzyme&Protease |
| Background | It can be used to resist the loss of learning and memory ability induced by scopolamine, morphine and methamphetamine in mice. |
| Biological Activity | Pseudoginsenoside F11, a natural product found in American ginseng but not in Asian ginseng, is a novel partial PPARγ agonist.[1] |
| In Vitro | Pseudoginsenoside F11(PF11)promotes the differentiation of 3T3-L1 preadipocytes. It promotes adipogenesis by activating PPARγ[1]. PF11 significantly suppresses the release of ROS and proinflammatory mediators induced by LPS in a microglial cell line N9 including NO，PGE2，IL-1β，IL-6 and TNF-α. Moreover，PF11 inhibits interaction and expression of TLR4 and MyD88 in LPS-activated N9 cells，resulting in an inhibition of the TAK1/IKK/NF-κB signaling pathway. PF11 also inhibited the phosphorylation of Akt and MAPKs induced by LPS in N9 cells[2]. |
| In Vivo | In in vivo studies，PF11 mitigated the microglial activation and proinflammatory factors expression obviously in both cortex and hippocampus in mice injected intrahippocampally with LPS. PF11 exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB，MAPKs and Akt signaling pathways. It may exert therapeutic effects for neurodegenerative disease associated with neuroinflammation[2]. |
| Cell Experiment | 3T3-L1 preadipocytes are induced to differentiate with 0，20，40 μM Pseudoginsenoside F11(p-F11)or 0.5 μM rosiglitazone in the absence or presence of 20 μM GW9662 for 8 days.[1] |
| Data Literature Source | [1] Wu G，et al. PPAR Res. 2013，2013: 701017. [2] Wang X，et al. Neuropharmacology. 2014，79:642-56. |
| Unit | Bottle |
| Specification | 5mg 10mg 10mM*1mL in DMSO |
是一种新型的部分 PPARγ 激动剂。
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Manual Download
